Leaders in Pharmaceutical Business Intelligence (LPBI) Group

6/30/2020

Chasing change: Innovation and patent
activity during COVID-19

A report on the pandemic’s impact on the global
R&D community and innovation lifecycle

Reporters: Aviva Lev-Ari, Ph.D., RN & Gail S. Thornton, M.A.

Published by Clarivate Derwent

In just a few short months, COVID-19 swept through the world. While many aspects of everyday life have altered as the pandemic has gripped the globe, society at large has been and remains remarkably resilient.

To understand the impact of COVID-19 on the world’s innovators, we asked organizations from a cross-section of industries globally about how the pandemic has affected their organizations’ innovation strategies.

We are pleased to share the results with you in the report, “Chasing change: Innovation and patent activity during COVID-19.”

SOURCE:

https://clarivate.com/derwent/wp-content/uploads/sites/3/dlm_uploads/2020/06/DW507408683-COVID-19-Report_FINAL.pdf?utm_campaign=EM1_Report_Derwent_COVID_19_Survey_Apr_IPS_Global_2020_ClientsProspects

Other related article published in this Open Access Online Scientific Journal include the following:

Corticosteroid, Dexamethasone Improves Survival in COVID-19: Deaths reduction by 1/3 in ventilated patients and by 1/5 in other patients receiving oxygen only

Reporter: Aviva Lev-Ari, PhD, RN https://pharmaceuticalintelligence.com/2020/06/27/corticosteroid-dexamethasone-improves-survival-in-covid-19-deaths-reduction-by-1-3-in-ventilated-patients-and-by-1-5-in-other-patients-receiving-oxygen-only/

###